Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs
Authors
Keywords
-
Journal
Nucleic Acid Therapeutics
Volume 32, Issue 5, Pages 369-377
Publisher
Mary Ann Liebert Inc
Online
2022-09-30
DOI
10.1089/nat.2021.0112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia
- (2020) PadmaKumar Narayanan et al. Nucleic Acid Therapeutics
- Population Pharmacokinetic–Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin Amyloidosis
- (2020) Rosie Z. Yu et al. Nucleic Acid Therapeutics
- Immunogenicity Assessment of Inotersen, a 2′-O-(2-Methoxyethyl) Antisense Oligonucleotide in Animals and Humans: Effect on Pharmacokinetics, Pharmacodynamics, and Safety
- (2020) Rosie Z. Yu et al. Nucleic Acid Therapeutics
- Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012‐2018
- (2020) Hobart Rogers et al. CTS-Clinical and Translational Science
- Treating Disease at the RNA Level with Oligonucleotides
- (2019) Arthur A. Levin NEW ENGLAND JOURNAL OF MEDICINE
- Effective presentation of immunogenicity risk assessments and related data in regulatory dossiers
- (2019) Paul Chamberlain Bioanalysis
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity for antisense oligonucleotides: a risk-based assessment
- (2019) Christopher C Stebbins et al. Bioanalysis
- 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)
- (2019) Steven Piccoli et al. Bioanalysis
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2ʹ-MOE-Modified Antisense Oligonucleotide
- (2018) Padmakumar Narayanan et al. TOXICOLOGICAL SCIENCES
- Drug-induced Glomerulonephritis: The Spectre of Biotherapeutic and Antisense Oligonucleotide Immune Activation in the Kidney
- (2018) Kendall S. Frazier et al. TOXICOLOGIC PATHOLOGY
- CpG Still Rocks! Update on an Accidental Drug
- (2018) Arthur M. Krieg Nucleic Acid Therapeutics
- 2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 – LBA/cell-based assays: immunogenicity, biomarkers and PK assays)
- (2018) Lauren Stevenson et al. Bioanalysis
- Oligonucleotide-based pharmaceuticals: Non-clinical and clinical safety signals and non-clinical testing strategies
- (2017) Enni-Kaisa Mustonen et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Assay signal as an alternative to titer for assessment of magnitude of an antidrug antibody response
- (2017) Marta Starcevic Manning et al. Bioanalysis
- Assessment of the Effects of 2′-Methoxyethyl Antisense Oligonucleotides on Platelet Count in Cynomolgus Nonhuman Primates
- (2017) Scott P. Henry et al. Nucleic Acid Therapeutics
- The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
- (2017) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers
- (2016) Stanley T Crooke et al. MOLECULAR THERAPY
- Considerations for the Characterization and Interpretation of Results Related to Alternative Complement Activation in Monkeys Associated with Oligonucleotide-Based Therapeutics
- (2016) Scott P. Henry et al. Nucleic Acid Therapeutics
- Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2′-O-Methoxyethyl Modified Antisense Oligonucleotide
- (2016) Lijiang Shen et al. Nucleic Acid Therapeutics
- Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance
- (2016) Justine Collet-Brose et al. Journal of Immunology Research
- Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective
- (2015) Yow-Ming C. Wang et al. AAPS Journal
- Comparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13)
- (2015) Ji Soo Kim et al. Expert Review of Clinical Immunology
- Scientific and Regulatory Policy Committee Points-to-consider Paper*
- (2015) Jeffery A. Engelhardt et al. TOXICOLOGIC PATHOLOGY
- Oligonucleotide-Based Drug Development
- (2015) Jian Wang et al. Therapeutic Innovation & Regulatory Science
- Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
- (2014) G. Shankar et al. AAPS Journal
- Immunogenicity testing strategy and bioanalytical assays for antibody–drug conjugates
- (2013) Sarah A Hoofring et al. Bioanalysis
- Strategic selection and development of immunogenicity binding methods
- (2012) Ana T Menendez Bioanalysis
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
- (2009) Rafael Ponce et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search